Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Nucl Med Biol ; 28(1): 51-7, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11182564

ABSTRACT

5-bromodeoxyuridine (BUdR) provides in vitro measures of tumor cell proliferation. We used positron emission tomography to study tissue and plasma kinetics of [76Br]BUdR in tumor-bearing animals. In order to account for the slow washout of the major plasma metabolite, [76Br]bromide, a mathematical correction for the distribution volume of [76Br]bromide was applied. However, following correction specific tumor tracer retention was low or even zero and did not correlate with independent measures of proliferation. The kinetic characteristics of [76Br]BUdR make this tracer unsuitable for proliferation imaging.


Subject(s)
Bromodeoxyuridine/pharmacokinetics , Neoplasms/metabolism , Radiation-Sensitizing Agents/pharmacokinetics , Animals , Bromine Radioisotopes/blood , Bromodeoxyuridine/blood , Cats , Dogs , Female , Flow Cytometry , Half-Life , Male , Mathematics , Neoplasms/diagnostic imaging , Neoplasms/pathology , Tissue Distribution , Tomography, Emission-Computed
2.
Nucl Med Biol ; 26(6): 673-9, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10587106

ABSTRACT

5-Bromo-2'-deoxyuridine (BrUdR) labeled with 77Br and 76Br was compared with 5-iodo-2'-deoxyuridine (IUdR) labeled with 125I or 131I, first in vitro then in in vivo experiments in mice. The results showed a significantly higher incorporation of BrUdR into DNA than IUdR, which can be explained by the greater similarity (size and surface hydrophilicity of the molecules) of BrUdR to thymidine. Both tracers are dehalogenated quickly in vivo but not in vitro. Free bromide is excreted more slowly than iodide, resulting in a higher background activity level after the application of [76Br]BrUdR and compensates for the favorable DNA incorporation. 76Br has more favorable properties than 124I for imaging purposes with positron emission tomography (PET) because of a very convenient half-life (16 h vs. 4.15 days) and about double the positron yield per decay. However, the more favorable physical properties are balanced by the slower excretion and thus the estimated radiation dose is higher in the case of 76Br than 124I. Thus, both tracers, [124I]IUdR and [76Br]BrUdR are potentially suitable but not optimal to measure cell proliferation in vivo. The difference between the two tracers is small and the extrapolation from mice to human difficult, and thus it cannot be concluded if one of the tracers would be better than the other for imaging of cancer patients.


Subject(s)
Bromine Radioisotopes/pharmacokinetics , Bromodeoxyuridine/pharmacokinetics , Tomography, Emission-Computed , Animals , Cell Division , Cyclotrons , Half-Life , Humans , Idoxuridine/pharmacokinetics , Iodine Radioisotopes/pharmacokinetics , Mice , Tissue Distribution
3.
Nucl Med Biol ; 25(3): 261-5, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9620632

ABSTRACT

To circumvent radionuclide accumulation in nontarget tissues when employing metallic radionuclides for radioimmunoscintigraphy or radioimmunotherapy, we have investigated the effect of the chelating agent deferroxamine (DFO) on the biodistribution of 67Ga following its administration attached to intact monoclonal antibody MAb35 and its F(ab')2 fragment. Following administration of 67Ga-labeled MAb35, DFO accelerated whole-body elimination of 67Ga and reduced its accumulation in several normal tissues, including liver, spleen and kidney. No reduction in tumor accumulation of 67Ga was observed. Following administration of 67Ga-labeled F(ab')2 fragment, kidney accumulation was higher than with the intact antibody (29% and 4% ID/g, respectively) and blood levels lower (0.69% and 5% ID/g, respectively). Again, no alteration in tumor accumulation of 67Ga was seen following DFO, although liver, kidney and blood levels were reduced and whole-body elimination accelerated.


Subject(s)
Antibodies, Monoclonal/metabolism , Deferoxamine/pharmacology , Gallium Radioisotopes/pharmacokinetics , Gallium Radioisotopes/therapeutic use , Animals , Chelating Agents , Colonic Neoplasms/metabolism , Colonic Neoplasms/radiotherapy , Humans , Immunoglobulin Fab Fragments/metabolism , Kidney/metabolism , Kinetics , Mice , Mice, Nude , Radioimmunodetection , Radioimmunotherapy , Tissue Distribution/drug effects , Transplantation, Heterologous
4.
Br J Anaesth ; 75(3): 269-73, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7547041

ABSTRACT

Although it is accepted that during i.v. regional anaesthesia (IVRA) local anaesthetic can leak under the tourniquet into the systemic circulation, no published study has evaluated this leak quantitatively. In volunteers, during two random sessions, we have simulated IVRA using standard techniques with a radiolabelled compound which is chemically similar to lignocaine and has comparable tissue distribution (0.1 mg of HIDA labelled with 100 muCi of 99mTc in 40 ml of saline). The decrease in radioactivity was measured with a gamma camera for the 20 min of tourniquet inflation and for the 20 min of washout after cuff deflation. While the tourniquet was inflated, the leak for the lower limb (mean 29 (SD 8) %) was significantly greater (P < 0.004) than the leak for the upper limb (15 (5) %). Moreover, in each of 10 volunteers, the leak was always greater for the lower than the upper limb. During the first 3 min after tourniquet deflation the loss of radioactivity was 58 (8) % of the maximal amount for the upper limb and 39 (8) % for the lower limb (P < 0.001). As the leak under the tourniquet was significantly greater for the lower than the upper limb, we conclude that IVRA for the lower limb can be associated more frequently with a shorter duration of successful anaesthesia and/or failure.


Subject(s)
Anesthesia, Local , Arm/surgery , Leg/surgery , Tourniquets , Adult , Female , Humans , Imino Acids , Male , Middle Aged , Organotechnetium Compounds , Radioisotope Dilution Technique , Technetium Tc 99m Lidofenin , Time Factors , Tourniquets/adverse effects , Venous Pressure
5.
J Nucl Med ; 36(3): 420-9, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7884504

ABSTRACT

UNLABELLED: Biodistribution and tumor uptake of a chimeric human-mouse monoclonal antibody (MAb) and the original mouse MAb have been comparatively studied. METHODS: Eighteen patients with suspected colorectal cancer scheduled for surgery underwent immunoscintigraphy with 123I-labeled chimeric anti-CEA MAb. Iodine-125 and 131I trace-labeled chimeric and original mouse MAb were simultaneously injected for biodistribution studies. RESULTS: Similar serum kinetics and a low immunogenicity were observed for both antibodies. Mean binding capacity to CEA measured in PBS after radiolabeling was identical for both MAbs and it was slightly decreased when measured in serum 1-4 hr after injection. Radiochromatograms of patients sera showed immune complex formation related to the amount of circulating CEA. Postoperative ex vivo radioactivity counting in tissue samples revealed similar antibody distributions with notably similar antibody uptakes in tumors. High tumor uptakes (between 0.02 to 0.06% injected dose per g) were observed in 3 of 13 patients operated for primary or metastatic colorectal cancer. CONCLUSION: In this dual-label technique, the radioiodinated anti-CEA IgG4 chimeric MAb and the original mouse IgG1 MAb were shown to have very similar behavior in colorectal cancer patients.


Subject(s)
Antibodies, Monoclonal , Carcinoembryonic Antigen/immunology , Colorectal Neoplasms/diagnostic imaging , Radioimmunodetection , Adult , Aged , Aged, 80 and over , Animals , Antibodies, Monoclonal/pharmacokinetics , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/surgery , Female , Humans , Male , Mice , Middle Aged , Recombinant Fusion Proteins/pharmacokinetics
6.
Schweiz Rundsch Med Prax ; 82(50): 1457-61, 1993 Dec 14.
Article in French | MEDLINE | ID: mdl-8290839

ABSTRACT

The distribution of specific radiolabeled biological compounds in tumor tissues can be imaged by positron emission tomography (PET). The substance used is fluorodeoxyglucose, labeled with the positron emitter fluorine-18. This substance is partly trapped in tumor cells with increased glucose metabolism. This noninvasive imaging technique allows to assess quantitatively and in three dimensions the extent of metastatic disease in ENT cancer. The case presented illustrates the important value we foresee for this new imaging modality in the presurgical staging of cervical metastatic disease of ENT tumors. Sensitivity and specificity of the PET-FDG imaging technique for the loco-regional staging of ENT cancer are, according to preliminary results of an ongoing, prospective clinical study, very high.


Subject(s)
Otorhinolaryngologic Neoplasms/diagnostic imaging , Tomography, Emission-Computed , Aged , Combined Modality Therapy , Deoxyglucose/analogs & derivatives , Female , Fluorodeoxyglucose F18 , Humans , Lymphatic Metastasis/diagnostic imaging , Neck , Neoplasm Staging , Otorhinolaryngologic Neoplasms/pathology , Otorhinolaryngologic Neoplasms/therapy , Radiotherapy Dosage , Radiotherapy, High-Energy
7.
Infect Immun ; 61(10): 4182-7, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8104895

ABSTRACT

The role of platelets was investigated in two models of lipopolysaccharide (LPS)-induced toxicity in mice: the systemic reaction, provoked by intravenous LPS injection in D-galactosamine-sensitized recipients, which results in host death, and the local reaction, elicited in the skin by sequential injections of LPS and tumor necrosis factor alpha at 24-h intervals, which results in hemorrhagic necrosis. In both models, the depletion of platelets with a rabbit polyclonal or a mouse monoclonal antiplatelet immunoglobulin G afforded significant protection. In the local reaction, studies of the distribution of 111In-labelled platelets as well as optical and electron microscopy showed that platelets are localized in the dermal venules before hemorrhage occurs. Anti-CD11a (LFA-1) and anti-CD54 (ICAM-1) monoclonal antibodies prevented both platelet localization and hemorrhagic necrosis, and these determinants were detected on mouse platelets by immunofluorescence. The antiplatelet monoclonal antibody did not reduce the localization of polymorphonuclear leukocytes in the dermal venules, as shown by histological sections. Thus, in the local reaction, the stimulation with LPS and tumor necrosis factor alpha leads to a binding of platelets to the endothelium of venules by their beta 2 integrins, which seems necessary for the development of the hemorrhagic necrosis.


Subject(s)
Blood Platelets/physiology , Endothelium, Vascular/physiopathology , Lipopolysaccharides/toxicity , Animals , Cell Adhesion Molecules/physiology , Female , Galactosamine/administration & dosage , Intercellular Adhesion Molecule-1 , Lymphocyte Function-Associated Antigen-1/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred CBA , Tumor Necrosis Factor-alpha/metabolism
8.
J Nucl Med ; 33(10): 1766-73, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1403142

ABSTRACT

Previous experimental results in nude mice showing that radiolabeling the monoclonal antibody anti-CEA 35 with 67Ga-aminooxyacetyldeferroxamine could give better tumor localization than radioiodination prompted us to initiate the present clinical study. The 67Ga-labeled antibody anti-CEA 35 (185 MBq, 0.7-1.7 mg) was injected preoperatively into 14 patients for colorectal carcinoma imaging. The same antibody labeled with 125I (3.7 MBq, 0.25 mg) was injected simultaneously to compare the 67Ga and 125I dose recoveries in surgical specimens. Twelve of 14 primary tumors gave a positive 67Ga scintigraph. The mean %ID/g recovered in all tumors 3-9 days after injection was significantly higher for 67Ga (0.019%) than for 125I (0.005%) (p < 0.001, paired t test). The tumor-to-normal tissue ratios were generally higher for 67Ga, with the exception of liver. We conclude that 67Ga-aminooxyacetyldeferroxamine improved immunoscintigraphy outside the liver, particularly in the pelvic region. We also show that deferroxamine infusion accelerates the excretion of 67Ga in eight patients and propose that this could lead to further improvement of immunoscintigraphy.


Subject(s)
Colorectal Neoplasms/diagnostic imaging , Deferoxamine , Gallium Radioisotopes , Gallium , Radioimmunodetection , Aged , Carcinoembryonic Antigen/immunology , Deferoxamine/analogs & derivatives , Female , Humans , Iodine Radioisotopes , Male , Tomography, Emission-Computed, Single-Photon
9.
Int J Rad Appl Instrum B ; 17(5): 487-94, 1990.
Article in English | MEDLINE | ID: mdl-2391244

ABSTRACT

Biosynthetically-radiolabeled MoAbs provide a tool to test whether structural modifications of the MoAbs influence the results of conventional immunoscintigraphy. When biosynthetically-labeled 75Se-MoAbs from the Mel-14 hybridoma were injected into mice with melanoma xenografts, the high tumor recovery supported the hypothesis of a structural advantage. The increased excretion of 75Se obtained by supplementing the diet of the mice with cold selenium did not reduce the tumor recovery, demonstrating an accumulation of the free radionuclide in normal tissue.


Subject(s)
Antibodies, Monoclonal/pharmacokinetics , Antigens, Neoplasm/immunology , Melanoma/metabolism , Selenium Radioisotopes/pharmacokinetics , Administration, Oral , Animals , Humans , Isotope Labeling/methods , Melanoma/diagnostic imaging , Melanoma/immunology , Mice , Mice, Nude , Neoplasm Transplantation , Radionuclide Imaging , Selenium/administration & dosage , Tissue Distribution , Transplantation, Heterologous
10.
Int J Rad Appl Instrum B ; 17(5): 495-7, 1990.
Article in English | MEDLINE | ID: mdl-2391245

ABSTRACT

The biodistribution of 75Se and 125I were compared in nude mice bearing melanomas and injected simultaneously with biosynthetically-labeled 75Se-MoAbs and radioiodinated 125I-MoAbs from the same anti-melanoma hybridoma. The 75Se dose recovery in the tumor (day 10) was twice that for 125I, but the tumor to normal tissue ratios were identical. It is concluded that biosynthetically-labeled MoAbs survive better in vivo, while the tumor to normal tissue ratios are governed by the excretion rate of labeled MoAb catabolytic products.


Subject(s)
Antibodies, Monoclonal/pharmacokinetics , Antigens, Neoplasm/immunology , Iodine Radioisotopes/pharmacokinetics , Melanoma/metabolism , Selenium Radioisotopes/pharmacokinetics , Animals , Humans , Isotope Labeling/methods , Melanoma/diagnostic imaging , Melanoma/immunology , Mice , Mice, Nude , Neoplasm Transplantation , Radionuclide Imaging , Tissue Distribution , Transplantation, Heterologous
11.
Graefes Arch Clin Exp Ophthalmol ; 228(6): 510-2, 1990.
Article in English | MEDLINE | ID: mdl-2176168

ABSTRACT

The aim of the present study was to quantify in man the distribution and clearance of two aqueous sodium hyaluronate (SH) solutions of 0.125% and 0.250% after the administration of 25 microliters onto the cornea. Isotonic phosphate buffer (PB) was used as a reference instillation. No systemic or local medication was given to the seven 18- to 30-year-old, healthy male volunteers. A detailed evaluation of the anterior segment of the eye, as well as a Schirmer test and a break-up time measurement, yielded results within the normal range. The clearance of 0.125% and 0.250% SH solutions radiolabelled with sodium pertechnetate Tc-99m was measured by gamma scintigraphy and compared with that of a PB solution tagged with the same radiolabel. There was no statistically significant difference between the quantities of 0.125% SH and PB solutions remaining in the precorneal space at 20 min (paired t-test, P = 0.78, n = 7). However, in comparing the 0.250% SH with the PB solution, we observed a statistically significant difference (P = 0.01, n = 7) in the amount remaining in the precorneal space after the same interval. Actually, 53% of the radiolabelled 0.250% SH solution remained on the cornea as compared with 30% for the 0.125% SH solution and 18.3% for the PB solution. These results suggest that an SH solution of 0.250% might have a prolonged residence time on the precorneal surface, and that SH could therefore be used as an additive in various drug-release systems for the eye.


Subject(s)
Cornea/metabolism , Hyaluronic Acid/pharmacokinetics , Administration, Topical , Adolescent , Adult , Anterior Eye Segment/diagnostic imaging , Anterior Eye Segment/metabolism , Cornea/diagnostic imaging , Humans , Hyaluronic Acid/administration & dosage , Male , Pharmaceutical Vehicles/pharmacokinetics , Radionuclide Imaging , Sodium Pertechnetate Tc 99m , Tears/metabolism
12.
Int J Cancer ; 43(6): 1188-94, 1989 Jun 15.
Article in English | MEDLINE | ID: mdl-2786509

ABSTRACT

We describe the preparation of the modified chelator aminooxyacetyl-ferrioxamine, and the replacement of its iron atom by 67Ga at high specific activity. The aminooxy function of this compound was allowed to react with the aldehyde groups generated by the periodate oxidation of the oligosaccharide of a mouse IgG1 monoclonal antibody (MAb) directed against carcino-embryonic antigen (CEA). The use of the aminooxy group allowed a stable bond to be formed between the chelon and the antibody with no need for reduction. Iron was removed from the ferrioxamine moiety and replaced by 67Ga either before or after conjugation of the chelon to the antibody. In either case the labelled antibody was injected into nude mice bearing a human colon carcinoma having the appropriate antigenicity. Unoxidized antibody, labelled with 125I by conventional methods, was co-injected as an internal control. Additional control experiments were carried out with a non-immune IgG using the same 67Ga-labelled modified chelon as above. The in vivo distribution of the modified antibodies was evaluated at various times between 24 and 96 hr after injection. The methods used were gamma-camera imaging and, more quantitatively, gamma-counting of the various organs after dissection. Interestingly, with the metal-chelon-labelled antibody, the intensity and specificity of tumor labelling was comparable and in some cases superior to the results obtained with radio-iodinated antibody. In particular, there was almost no increase in liver and spleen uptake of radioactive metal relative to radio-iodine, contrary to what has been observed with most antibodies labelled with 111In after conjugation with DTPA.


Subject(s)
Deferoxamine/analogs & derivatives , Immunotoxins/metabolism , Animals , Antibodies, Monoclonal , Deferoxamine/pharmacokinetics , Gallium Radioisotopes , Immunoglobulin G/metabolism , Iodine Radioisotopes , Mice , Mice, Nude , Structure-Activity Relationship , Tissue Distribution
14.
Clin Exp Immunol ; 69(1): 188-97, 1987 Jul.
Article in English | MEDLINE | ID: mdl-3498586

ABSTRACT

The main clinical features in four patients with IgG1k paraproteinaemia and acquired complement deficiency included xanthomatous skin lesions (in three), panniculitis (in three) and hepatitis (in two). Hypocomplementaemia concerned the early classical pathway components--in particular C1q. Metabolic studies employing 125I-C1q revealed a much faster catabolism of this protein in the four patients than in five normal controls and three patients with cryoglobulinaemia (mean fractional catabolic rates respectively: 23.35%/h; 1.44%/h; 5.84%/h). Various experiments were designed to characterize the mechanism of the hypocomplementaemia: the patients' serum, purified paraprotein, blood cells, bone marrow cells, or xanthomatous skin lesions did not produce significant complement activation or C1q binding. When three of the patients (two with panniculitis and hepatitis) were injected with 123I-C1q, sequential gamma-camera imaging demonstrated rapid accumulation of the radionuclide in the liver, suggesting that complement activation takes place in the liver where it could produce damage.


Subject(s)
Complement Activating Enzymes/metabolism , Complement Activation , Complement C1/metabolism , Complement Pathway, Classical , Liver/immunology , Paraproteinemias/immunology , Adult , Bone Marrow/immunology , Complement C1q , Complement System Proteins/deficiency , Cryoglobulins/immunology , Female , Humans , Immunoglobulin G/immunology , Male , Middle Aged , Skin Diseases/immunology , Xanthomatosis/immunology
15.
Nucl Med Commun ; 6(12): 795-803, 1985 Dec.
Article in English | MEDLINE | ID: mdl-2421219

ABSTRACT

The sensitivity and specificity of single photon emission tomography with 57Co-labelled bleomycin (57Co-BLM) for the detection of cancer was determined from a prospective study involving a large group of patients selected to investigate roentgenographic abnormalities. Eighty-four of the 104 patients studied had malignant disease, of whom 76 had a positive scintigram. Eighteen of the 20 patients with benign disorders had a negative scintigram. The sensitivity and specificity was therefore 90.5 and 90% respectively. For the subset of patients who underwent investigation below the diaphragm, the sensitivity was 85.7%, while for investigation above the diaphragm, it reached 95.2% (this excluded reconstructions on the bladder level, because it produced large artifacts). This study leads to the conclusion that SPECT can be used specifically to investigate unidentified X-ray abnormality and diagnose malignancy using 57Co-BLM. In addition, we propose further investigation to evaluate the usefulness of this method in staging cancer.


Subject(s)
Bleomycin , Cobalt Radioisotopes , Neoplasms/diagnostic imaging , Tomography, Emission-Computed , Aged , Bayes Theorem , Female , Humans , Male , Middle Aged
16.
J Cell Biol ; 99(5): 1706-15, 1984 Nov.
Article in English | MEDLINE | ID: mdl-6333426

ABSTRACT

We report here that interleukins have a dramatic effect on extracellular matrix production by cultured endothelial cells. Human umbilical vein endothelial cells incubated with growth media conditioned by lectin-activated human peripheral blood mononuclear leukocytes undergo marked changes in cell shape and elaborate a highly organized extracellular material that is not detectable in untreated cultures. This material has the following characteristics: (a) it is not recognizable by electron microscopy unless the cationic dye, Alcian blue, is added to the fixative; (b) it is visualized as a network of branching and anastomosing fibrils of various thickness that can be resolved into bundles of fine filaments; (c) it is associated with the cell surface, extends between contiguous cells, and coats the culture substrate; (d) it is removed by digestion with glycosaminoglycan-degrading enzymes, such as crude heparinase and chondroitinase ABC. These results demonstrate that soluble factors released by activated peripheral blood mononuclear leukocytes (interleukins) stimulate cultured human umbilical vein endothelial cells to produce a highly structured pericellular matrix containing glycosaminoglycans (probably chondroitin sulfate and/or hyaluronic acid) as a major constituent. We speculate that this phenomenon corresponds to an early step of angiogenesis as observed in vivo as a consequence of interleukin release.


Subject(s)
Endothelium/physiology , Extracellular Matrix/metabolism , Glucuronidase , Glycosaminoglycans/metabolism , Interleukin-2/physiology , Alcian Blue , Animals , Cells, Cultured , Chondroitin Lyases/pharmacology , Extracellular Matrix/drug effects , Extracellular Matrix/ultrastructure , Glycoside Hydrolases/pharmacology , Humans , Leukocytes/physiology , Microscopy, Electron , Phytohemagglutinins/pharmacology , Umbilical Veins
17.
Schweiz Med Wochenschr ; 113(40): 1477-9, 1983 Oct 08.
Article in French | MEDLINE | ID: mdl-6648431

ABSTRACT

In the 111-indium-leukocyte scan method described by M. L. THAKUR et al. in 1977 for the diagnosis of abdominal abscesses the whole leukocyte fraction from a blood sample is labeled and injected into patients. We propose a modification in which purified granulocytes are used. The results of 43 granulocyte scans show that this modification does not diminish the sensitivity of the method. Furthermore, it allows the detection of abscesses in a shorter time (2-4 hours after injection) and with 111-indium doses (200 muCi) at least 3 times lower than in the original method. Increased specificity can also be expected.


Subject(s)
Abscess/diagnostic imaging , Granulocytes/transplantation , Indium , Radioisotopes , Abdomen , Adolescent , Adult , Aged , Female , Granulocytes/metabolism , Humans , Middle Aged , Radionuclide Imaging
18.
J Immunol ; 128(3): 1159-62, 1982 Mar.
Article in English | MEDLINE | ID: mdl-7035558

ABSTRACT

Conjugates of cytotoxic T lymphocytes attached to their target cells were studied by double immunofluorescence on fixed smears to detect simultaneously the localization of actin and myosin within the cells. Actin was found to be polarized in the area of attachment of the lymphocytes (but not of the target cells), whereas myosin remained evenly distributed in the cytoplasm. When living conjugates were brought to 37 degrees C to induce cytotoxicity, this pattern remained unchanged, but observation by interference reflexion microcinematography revealed a high motility of the lymphocytes in the contact area. This localized motility in the area of attachment associated with a peculiar actin polarization, which has no equivalent in any type of cell contact presently known, could represent a necessary step in the sequence of events leading to target cell killing by cytotoxic T lymphocytes.


Subject(s)
Actins/immunology , Cytotoxicity, Immunologic , Myosins/immunology , T-Lymphocytes/immunology , Animals , Binding Sites , Cell Movement , Cytoplasm/analysis , Cytoplasm/immunology , Fluorescent Antibody Technique , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Microscopy, Interference , Microscopy, Phase-Contrast , T-Lymphocytes/analysis , T-Lymphocytes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...